Phase II Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

Conditions

Kidney

Phase II

What is the purpose of this trial?

Phase II trial of nivolumab in 120 treatment naïve patients with ccRCC

  • Trial with
    Hoosier Cancer Research Network, Inc
  • Start Date
    05/09/2019
  • End Date
    01/31/2020

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8348

Trial Image

For more information about this study, contact:

Neta Shanwetter Levit

  • Last Updated
    05/13/2019
  • Study HIC
    #2000022534